Hardman & Co Research Hardman & Co Q&A on Duke Capital (DUKE): Equity raise and third-party capital update 20-Nov-2024 / 10:30 GMT/BST The issuer is
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in
What’s in store for biotech VCs next year? Will Pfizer’s new R&D head do enough to appease investors? And should Adam get a position under
A dozen experts on women’s health are demanding the Federation of State Medical Boards remove a new documentary about menopause from its continuing medical education
What You Should Know: – Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed
What You Should Know: – Tassat Group, Inc., the leading provider of private permissioned blockchain-based real-time settlement solutions, today announced its strategic partnership with Veuu, an
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Philips is updating use instructions
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Identifeye Health, a startup looking to make
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Henry Schein said Wednesday it
Good morning, I’m back! And I can barely believe all the news that happened while I was away. On vacation, my biggest concern was a